Lazard Asset Management’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17K | Sell |
1,024
-2,529
| -71% | -$42K | ﹤0.01% | 2135 |
|
|
2025
Q1 | $77K | Buy |
+3,553
| New | +$77K | ﹤0.01% | 1880 |
|
|
2024
Q4 | – | Sell |
-3,202
| Closed | -$92K | – | 2271 |
|
|
2024
Q3 | $92K | Sell |
3,202
-2,993
| -48% | -$86K | ﹤0.01% | 1793 |
|
|
2024
Q2 | $237K | Buy |
6,195
+3,387
| +121% | +$130K | ﹤0.01% | 1506 |
|
|
2024
Q1 | $165K | Sell |
2,808
-79,703
| -97% | -$4.68M | ﹤0.01% | 1371 |
|
|
2023
Q4 | $4.94M | Sell |
82,511
-33,378
| -29% | -$2M | 0.01% | 686 |
|
|
2023
Q3 | $4.41M | Buy |
115,889
+104,805
| +946% | +$3.99M | 0.01% | 724 |
|
|
2023
Q2 | $1.01M | Sell |
11,084
-24,220
| -69% | -$2.2M | ﹤0.01% | 989 |
|
|
2023
Q1 | $2.33M | Sell |
35,304
-49,516
| -58% | -$3.27M | ﹤0.01% | 888 |
|
|
2022
Q4 | $4.39M | Buy |
84,820
+38,724
| +84% | +$2M | 0.01% | 744 |
|
|
2022
Q3 | $3.15M | Buy |
46,096
+34,053
| +283% | +$2.33M | ﹤0.01% | 799 |
|
|
2022
Q2 | $544K | Buy |
12,043
+9,360
| +349% | +$423K | ﹤0.01% | 1097 |
|
|
2022
Q1 | $136K | Buy |
+2,683
| New | +$136K | ﹤0.01% | 1322 |
|
|
2021
Q4 | – | Sell |
-1,236
| Closed | -$40K | – | 2278 |
|
|
2021
Q3 | $40K | Buy |
+1,236
| New | +$40K | ﹤0.01% | 1783 |
|
|
2021
Q2 | – | Sell |
-1,324
| Closed | -$56K | – | 1952 |
|
|
2021
Q1 | $56K | Sell |
1,324
-11,865
| -90% | -$502K | ﹤0.01% | 1385 |
|
|
2020
Q4 | $754K | Buy |
+13,189
| New | +$754K | ﹤0.01% | 925 |
|
|
2019
Q4 | – | Sell |
-52,655
| Closed | -$1.27M | – | 1525 |
|
|
2019
Q3 | $1.27M | Buy |
+52,655
| New | +$1.27M | ﹤0.01% | 721 |
|